Literature DB >> 30848834

Comparing Three Methods for Reducing Psychotropic Use in Older Demented Spanish Care Home Residents.

William B Weeks1, Manish K Mishra1, David Curto2, Curtis L Petersen1, Pedro Cano2, Yulin Hswen3, Silvia Villamarín Serra2, Glyn Elwyn1, Marjorie M Godfrey1, Pedro Sánchez Soro2, José Francisco Tomás2.   

Abstract

BACKGROUND/
OBJECTIVE: In nursing homes across the world, and particularly in Spain, there are concerns that psychotropic medications are being overused. For older Spanish nursing home residents who had dementia, we sought to evaluate the association between applying interventions designed to reduce inappropriate psychotropic medication use and subsequent psychotropic use.
DESIGN: Retrospective, propensity score-matched, controlled, patient-level observational analysis.
SETTING: A total of 45 nursing homes in Spain. PARTICIPANTS: A total of 1653 nursing home residents, aged 70 to 99 years, who had dementia and were prescribed an antipsychotic, anxiolytic, or antidepressant medication, 606 of whom received an intervention; the remainder served as propensity score-matched controls. INTERVENTION: Team Rounds, Screening Tool of Older Persons' Prescriptions (STOPP)/Screening Tool to Alert Doctors to Right Treatment (START) criteria, or a Patient Decision Aid. MEASUREMENTS: At 2 and 4 weeks following intervention: change from baseline drug class-specific milligram-equivalent daily dose (MEDD); at 2 weeks: patient falls and restraint use.
RESULTS: Within each intervention/drug-class cohort, intervention patients and matched controls had similar baseline demographic characteristics, Charlson scores, lengths of admission, and drug class-specific MEDDs. Compared to controls, patients exposed to Team Rounds experienced a 23.3% (95% confidence interval [CI] = 13.9%-32.8%) reduction in antipsychotic and a 23.1% (95% CI = 18.3%-28.0%) reduction in anxiolytic MEDDs; those exposed to Patient Decision Aids had a 24.8% (95% CI = 15.6%-33.9%) reduction in antipsychotic and a 31.8% (95% CI = 25.5%-38.2%) reduction in anxiolytic MEDDs; and those exposed to STOPP/START application had a 27.7% (95% CI = 22.4%-33.0%) reduction in antipsychotic and a 39.5% (95% CI = 35.5%-43.5%) reduction in anxiolytic MEDDs. Intervention-associated antidepressant MEDD reductions were statistically significant but less dramatic. Interventions were associated with higher rates of medication discontinuation, but not higher rates of deaths, patient falls, or physical restraints.
CONCLUSION: We found strong evidence that the interventions we studied were associated with reduced psychotropic use without commensurate harms, suggesting that such interventions should be incorporated into Spanish nursing home care models. Public reporting of psychotropic medication use in Spanish care homes may encourage care homes to regularly monitor psychotropic medication use and implement such instruments. J Am Geriatr Soc, 2019.
© 2019 The American Geriatrics Society.

Entities:  

Keywords:  Spain; clinical care; dementia; nursing homes; psychotropic medications

Mesh:

Substances:

Year:  2019        PMID: 30848834     DOI: 10.1111/jgs.15855

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  4 in total

1.  Reducing Psychotropic Use in Older Non-demented Spanish Care Home Residents: a Before-After Comparison of Three Methods.

Authors:  Curtis L Petersen; David Curto; Manish K Mishra; Pedro Cano; William B Weeks
Journal:  J Gen Intern Med       Date:  2019-11-11       Impact factor: 5.128

Review 2.  Interventions to optimize medication use in nursing homes: a narrative review.

Authors:  Anne Spinewine; Perrine Evrard; Carmel Hughes
Journal:  Eur Geriatr Med       Date:  2021-03-09       Impact factor: 1.710

3.  Use of Benzodiazepines and Z-Drugs in Nursing Home Residents with Dementia: Prevalence and Appropriateness.

Authors:  Dirk O C Rijksen; Sytse U Zuidema; Esther C de Haas
Journal:  J Alzheimers Dis Rep       Date:  2021-12-09

Review 4.  Inappropriate medications and physical function: a systematic review.

Authors:  Elizabeth Manias; Md Zunayed Kabir; Andrea B Maier
Journal:  Ther Adv Drug Saf       Date:  2021-07-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.